Bring your data — or generate it with us.
You do not need to be a sequencing client. Provide raw data from any source — your own lab, a collaborator, a public repository — or generate it in-house with Nucleome, and our bioinformatics team delivers publication-grade analysis with reproducible, versioned pipelines.
From first principles to expert-level analysis
New here? Start with Foundations. Planning a study or reviewing results? Jump to Practitioner or Expert. Each level builds on the one before it, so you can read this page as a short course or dip in where you need to.
Start here if you are new to this service — six ideas that explain what it is and why it matters.
What is bioinformatics analysis?
The computational interpretation of biological data — turning raw sequencing, mass-spectrometry, or array files into biological answers: which variants, which genes, which pathways, which candidates.
What does "analysis-only" mean?
You supply the raw data (from your lab, a collaborator, or a public repository) or generate it with Nucleome — we perform the computational analysis.
What is OmniIntegrate?
Nucleome's multi-omics integration pipeline: it jointly analyses two or more omics layers (e.g. RNA-seq + proteomics + metabolomics) to find shared biology, integrated pathways, and predictive models.
What is neoantigen discovery?
Identifying tumour-specific peptide candidates that could be recognised by the immune system — from tumour sequencing data through HLA-binding prediction — for vaccine and immunotherapy research.
What is siRNA discovery?
Designing small interfering RNAs against a target gene with minimal off-target risk — for knockdown experiments and therapeutic-development research.
What will I get?
Processed results (variant calls, count matrices, protein tables, candidate lists), publication-ready figures, a written report with methods, and reproducible pipeline documentation.
For scientists planning a project or reading a report: how each step works and how it can mislead.
Data intake and QC
Raw data is verified (checksums, integrity), quality-controlled (FastQC-class metrics, MS QC), and any issues are reported before analysis proceeds.
Pipeline execution
Documented, versioned workflows — BWA/GATK-class variant calling, STAR/Salmon-class transcriptomics, MaxQuant/FragPipe-class proteomics — with parameters reported in the deliverable.
Statistical analysis
Differential analysis with multiple-testing correction, enrichment analysis, and supervised models only with proper validation — we do not publish over-fitted PLS-DA or unvalidated classifiers.
Multi-omics integration (OmniIntegrate)
Latent-factor models (MOFA+/DIABLO-class), joint pathway mapping, and correlation networks — with permutation testing and cross-validation for any predictive model.
Neoantigen pipeline steps
Somatic variant calling → expression confirmation → HLA typing → binding prediction (NetMHCpan-class) → candidate ranking with evidence tiers — predictions clearly labelled as predictions.
siRNA design steps
Target-transcript analysis → guide design with seed-region and isoform specificity → SNP/variant avoidance → off-target scoring → ranked candidate list for empirical validation.
For study design: the decisions that determine whether the data answers your question.
Power and design before analysis
Sample size, batch structure, and confounders determine what any analysis can detect — we advise at design stage, before data exists.
Reproducibility standards
Pinned versions, containerised workflows, and full provenance — analyses can be regenerated and defended in review.
Neoantigen validation reality
Binding predictions are predictions: only a fraction of predicted binders are immunogenic. We tier candidates by evidence strength and flag what requires empirical validation.
siRNA off-target reality
Seed-mediated off-targeting is unavoidable in principle; design minimises it, and empirical validation (multiple independent guides, rescue experiments) remains essential.
Machine learning with integrity
Predictive models are trained with proper cross-validation, external validation where possible, and honest reporting of limitations — no leakage, no overfitting.
Public-data reanalysis
TCGA, GEO, ENCODE, and similar resources are reanalysed with full provenance — useful for validation cohorts and hypothesis generation.
- OmniIntegrate
- Nucleome's multi-omics integration pipeline (latent-factor modelling, joint pathways, ML).
- Neoantigen
- a tumour-specific peptide candidate for immune recognition, predicted from sequencing data.
- siRNA
- small interfering RNA; guides sequence-specific mRNA knockdown.
- MOFA+/DIABLO-class
- latent-factor and multi-omics integration frameworks.
- NetMHCpan-class
- peptide–MHC binding prediction tools.
- FDR
- false discovery rate; the multiple-testing standard for omics differential analysis.
Bioinformatics Analysis Services at Nucleome Informatics
Nucleome Informatics provides data-analysis-only bioinformatics services through two divisions: Biomedical and Agrigenomics: raw data must be supplied by the client or generated by Nucleome. Every analysis runs on documented, versioned pipelines with methods, parameters, and software versions reported in the deliverable.
- Reproducible analysis with documented software versions, parameters, and reference data
- Publication-ready figures and tables
- A written analysis report with methods, results, and interpretation notes
- Raw and processed output files (VCF, count matrices, feature tables, etc.)
- Consultation on study design before analysis begins — the cheapest place to fix a study is at design
Analysis portfolio
- Genomics: WGS/WES variant calling (SNV/indel, CNV, SV), annotation (VEP/ANNOVAR-class), ACMG-style classification support, trio and cohort analysis, GWAS and fine-mapping.
- Transcriptomics: bulk RNA-seq (alignment/quantification, differential expression, pathway analysis), single-cell RNA-seq (QC, clustering, trajectory, cell–cell communication), spatial transcriptomics.
- Epigenomics: ChIP-seq, ATAC-seq, bisulfite/methylation analysis.
- Metagenomics: 16S/ITS amplicon and shotgun analysis, MAG assembly, taxonomic and functional profiling.
- Proteomics & metabolomics: database-search reanalysis, differential abundance, PTM analysis, pathway mapping.
- Multi-omics integration — OmniIntegrate pipeline: joint analysis of two or more omics layers (genomics + transcriptomics + proteomics + metabolomics) — MOFA+/DIABLO-class factor analysis, joint pathway mapping, correlation networks, and machine-learning models with honest validation.
- Neoantigen discovery pipeline: somatic mutation calling from tumour WGS/WES → RNA-seq expression confirmation → HLA typing → peptide–MHC binding prediction (NetMHCpan-class tools) → prioritised neoantigen candidate list with evidence tiers.
- siRNA discovery pipeline: target-gene siRNA design with off-target minimisation (seed-region and transcript-isoform specificity analysis, SNP and variant avoidance), delivery-strategy notes, and ranked candidate guides for empirical validation.
- Custom pipeline development: bespoke workflows, Nextflow/Snakemake-class reproducibility, and deployment for your team.
Data handling
- Client raw data is analysed as provided; we verify data integrity (checksums, QC) before analysis and report any issues found.
- Data confidentiality is maintained under NDA; data is not reused or shared.
- Public-data reanalysis (TCGA, GEO, ENCODE, and similar) is supported with full provenance.
Biomedical and Agrigenomics data analysis
Our bioinformatics services are organised into two divisions, each with its own specialists and pipelines, sharing the same versioned, reproducible workflows.
Biomedical Data Analysis Services
For hospitals, pharma, biotech and academic groups working on human disease, cancer and therapeutics.
- Multi-omics integration (OmniIntegrate): joint analysis of genome, transcriptome, proteome and metabolome data with latent-factor models and validated machine learning
- Neoantigen discovery: tumour WGS/WES + RNA-seq → HLA typing → pMHC binding prediction → evidence-tiered candidates
- siRNA discovery: off-target-minimised guide design with isoform specificity and SNP avoidance
- Biomarker discovery: differential analysis, feature selection and cross-validated classifiers for diagnostic, prognostic and predictive markers
- Single-cell & spatial transcriptomics: QC, clustering, cell-type annotation, trajectories, cell–cell communication and spatial domains
- Clinical & cancer genomics: germline and somatic WGS/WES variant calling, CNV/SV, ACMG-style classification support
- Transcriptomics & epigenomics: bulk RNA-seq, fusions, splicing, ChIP/ATAC-seq and methylation
- Human microbiome: 16S and shotgun metagenomics for gut, oral and skin studies
Agrigenomics Data Analysis Services
For crop and livestock breeders, agricultural universities, ICAR institutes and agri-biotech companies.
- T2T genome assembly: telomere-to-telomere, gap-free chromosomes from long reads (HiFi/ONT ultra-long) with Hi-C scaffolding and haplotype phasing
- De novo genome assembly: draft-to-chromosome-level assemblies with polishing, BUSCO/QV completeness checks, and gene and repeat annotation
- Microbial genome assembly: complete bacterial and fungal genomes, plasmid resolution, AMR/virulence genes and pangenomes
- RNA-seq data analysis: differential expression in crops, livestock and non-model species; de novo transcriptome assembly; co-expression networks
- Population genomics & breeding: SNP discovery, GBS/ddRAD genotyping, diversity and structure, GWAS and QTL mapping, genomic selection support
- Comparative & pan-genomics: synteny, gene-family evolution, phylogenomics and pan-genome graphs
- Plant, animal & microbial multi-omics: integrating genome, transcriptome, metabolome and phenotype data with OmniIntegrate
- Environmental & agri-metagenomics: soil, rhizosphere, rumen and aquaculture microbiomes; MAG assembly and functional profiling
Every service, standard and advanced
Analysis-only: raw data must be supplied by the client or generated by Nucleome. The table maps each service, by division, to what its standard and advanced tiers cover.
| Service | Standard analysis | Advanced analysis |
|---|---|---|
| Biomedical data analysis | ||
| WGS / WES | Alignment, SNV/indel calling, variant annotation, QC reports | CNV/SV calling, trio de novo analysis, homozygosity mapping, ACMG-style classification support |
| Bulk RNA-seq | Alignment/quantification, differential expression, PCA | Pathway enrichment, alternative splicing, fusion detection, cell-type deconvolution |
| Single-cell RNA-seq | QC, clustering, cell-type annotation, marker genes | Trajectory and pseudotime, cell–cell communication, multi-sample integration |
| Spatial transcriptomics | Spot/cell QC, clustering, spatial expression plots | Cell-type deconvolution, spatial ligand–receptor analysis, tissue-domain detection |
| Epigenomics (ChIP / ATAC / methylation) | Peak calling, differential binding or methylation | Motif enrichment, regulatory-network linkage, multi-layer integration |
| Metagenomics (16S / shotgun) | Taxonomic profiling, diversity analysis | MAG assembly, functional profiling, strain-level analysis |
| Proteomics | Protein identification and quantitation, differential abundance | PTM site analysis, interactomics scoring, pathway enrichment |
| Metabolomics | Feature-table processing, differential abundance | Pathway-interaction networks, isotope-tracer and flux analysis |
| GWAS / genotyping | QC, association testing, Manhattan and QQ plots | Fine-mapping, polygenic risk scores, heritability, ancestry-aware models |
| Multi-omics (OmniIntegrate) | Joint PCA/UMAP, correlation networks | MOFA+/DIABLO-class factor models, validated machine-learning classifiers |
| Neoantigen discovery | Somatic variant calling, HLA typing, binding predictions | Expression-aware evidence tiering, immunogenicity features, vaccine-candidate ranking |
| siRNA discovery | Guide design with off-target scoring | Isoform-specific design, SNP/variant avoidance, ranked candidate panels |
| Agrigenomics data analysis (plant · animal · microbial) | ||
| T2T / de novo genome assembly | Long-read assembly, polishing, BUSCO and QV completeness, basic annotation | Hi-C scaffolding to chromosome or T2T level, haplotype-phased assemblies, full gene and repeat annotation |
| Microbial genome assembly | Complete genome assembly, annotation, AMR and virulence genes | Plasmid resolution, pangenome and comparative genomics |
| Plant & animal RNA-seq | Reference-based quantification and differential expression | De novo transcriptome assembly, co-expression networks (WGCNA-class), alternative splicing |
| Population genomics & breeding | SNP calling, genetic diversity and population structure | GWAS and QTL mapping, genomic selection support, selection-signature scans |
| Comparative & pan-genomics | Synteny and orthology analysis | Gene-family evolution, phylogenomics, pan-genome graphs |
| Agri-metagenomics | Taxonomic profiling of soil, rhizosphere or rumen samples | MAG assembly, functional and pathway profiling |
| Both divisions | ||
| Custom pipeline development | Bespoke workflow development for your data | Containerised deployment, documentation, and team handover |
"Standard" covers the core analysis that answers the primary question for each data type; "Advanced" covers deeper methods that need more project context and are scoped at the design consultation. Tier selection is confirmed per project before analysis begins — no analysis starts without an agreed scope.
How the service works, step by step
Multi-omics integration frameworks (MOFA+, DIABLO), peptide–MHC binding prediction (NetMHCpan), and siRNA design principles are established in the literature — see references below.
Built for the questions you are asking
The platforms, pipelines and standards behind this service.
OmniIntegrate pipeline
Nucleome's multi-omics integration workflow: MOFA+/DIABLO-class latent-factor modelling, joint pathway analysis, correlation networks, and machine learning — with permutation-based validation, not over-fitted claims.
Neoantigen discovery pipeline
End-to-end tumour-antigen prioritisation: somatic variants, expression confirmation, HLA typing, and peptide–MHC binding prediction — candidates ranked with evidence tiers for downstream validation.
siRNA discovery pipeline
Rules-based siRNA design with off-target minimisation: seed-region specificity, isoform coverage, SNP/variant avoidance, and ranked candidate guides for empirical testing.
Versioned, reproducible workflows
Every analysis runs on pinned software versions and reference data — your results can be regenerated and defended.
Full omics coverage
Genomics, transcriptomics, epigenomics, metagenomics, proteomics, and metabolomics — one team for all layers.
Consultation-first model
Study design, statistical power, and analysis planning are part of the service — before any data is processed.
Data analysis in pictures
Illustrative analyses showing the outputs your project report contains. All data below are simulated for illustration — not client results.
Service highlights
What you can expect from our team in Hyderabad.
Analysis-only flexibility
Bring raw data from any source — your lab, a collaborator, or a public repository — or generate it with Nucleome.
OmniIntegrate pipeline
Multi-omics integration with validated models — not over-fitted claims.
Neoantigen & siRNA pipelines
End-to-end candidate discovery with evidence tiers and honest validation requirements.
Reproducible by default
Pinned versions, documented parameters, and full provenance in every deliverable.
Full omics coverage
Genomics, transcriptomics, epigenomics, metagenomics, proteomics, metabolomics — one team.
Consultation-first
Study design and statistical power advice before analysis begins.
What this service does and does not cover
Frequently asked, in plain language
From the basics to the finer points of design and interpretation.
basicDo I need to be a sequencing client?
basicDo you analyse plant, animal and microbial data?
basicWhat data formats do you accept?
basicWhat is OmniIntegrate?
intermediateHow does the neoantigen discovery pipeline work?
intermediateHow does siRNA design minimise off-target effects?
intermediateHow do you ensure reproducibility?
advancedCan you reanalyse public datasets (TCGA, GEO)?
advancedCan you build a custom pipeline for my team?
advancedHow do you handle machine-learning models honestly?
advancedCan OmniIntegrate handle my specific combination of omics layers?
Key literature & resources
Selected sources behind the methods and reference values on this page. Figures labelled "schematic" or "illustrative" are generated for this page, not client data.
- Argelaguet R, et al. MOFA+: a statistical framework for disentangling and integrating multi-omics data. Genome Biology. 2020;21:111.
- Singh A, et al. DIABLO: an integrative approach for identifying key molecular drivers from multi-omics assays. Bioinformatics. 2019;35(17):3055–3062.
- Jurtz V, et al. NetMHCpan-4.0: improved peptide–MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. The Journal of Immunology. 2017;199(9):3360–3368.
- Hoof I, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics. 2009;61(1):1–13.
- Reynolds A, et al. Rational siRNA design for RNA interference. Nature Biotechnology. 2004;22(3):326–330.
- Jackson AL, et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA. 2006;12(7):1179–1187.
- Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15–21.
- McKenna A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Research. 2010;20(9):1297–1303.









